Cargando…

Correction: TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515443/ https://www.ncbi.nlm.nih.gov/pubmed/34645680 http://dx.doi.org/10.1136/jitc-2020-002044corr1

Ejemplares similares

TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer
por: Slattery, Karen, et al.
Publicado: (2021)

Correction for Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β
Publicado: (2014)

NK Cell Metabolism and TGFβ – Implications for Immunotherapy
por: Slattery, Karen, et al.
Publicado: (2019)

p35 is a Crucial Player in NK-cell Cytotoxicity and TGFβ-mediated NK-cell Dysfunction
por: Wong, Derek P., et al.
Publicado: (2023)

Correction to: Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer
por: Yao, Yuyuan, et al.
Publicado: (2019)

Correction: TGFβ-activation by dendritic cells drives Th17 induction and intestinal contractility and augments the expulsion of the parasite Trichinella spiralis in mice
por: Steel, Nicola, et al.
Publicado: (2021)

Correction to: microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signalings
por: Fang, Chi, et al.
Publicado: (2021)

Preventing Surgery-Induced NK Cell Dysfunction Using Anti-TGF-β Immunotherapeutics
por: Market, Marisa, et al.
Publicado: (2022)

Correction to: ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer
por: Sun, Xiaoqing, et al.
Publicado: (2022)

Correction: Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling
por: Roger, Elodie, et al.
Publicado: (2020)

Correction to: TGF‑β‑induced α‑SMA expression is mediated by C/EBPβ acetylation in human alveolar epithelial cells
por: Ding, Hui, et al.
Publicado: (2021)

Correction: Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
Publicado: (2022)

Correction: Comparative Analysis of TGF-β/Smad Signaling Dependent Cytostasis in Human Hepatocellular Carcinoma Cell Lines
Publicado: (2014)

Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells
por: Hutcheson, Iain R., et al.
Publicado: (2018)

Correction: ERBIN deficiency links STAT3 and TGF-β pathway defects with atopy in humans
por: Lyons, J.J., et al.
Publicado: (2017)

NK cell dysfunction in severe COVID-19: TGF-β-induced downregulation of integrin beta-2 restricts NK cell cytotoxicity
por: Barros-Martins, Joana, et al.
Publicado: (2022)

Correction: Overexpressing TGF-β1 in mesenchymal stem cells attenuates organ dysfunction during CLP-induced septic mice by reducing macrophage-driven
por: Liu, Feng, et al.
Publicado: (2022)

Correction: Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer
Publicado: (2020)

Correction: Doxorubicin-Mediated Bone Loss in Breast Cancer Bone Metastases Is Driven by an Interplay between Oxidative Stress and Induction of TGFβ
por: Rana, Tapasi, et al.
Publicado: (2013)

Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer
por: Ring, Alexander, et al.
Publicado: (2022)

Author Correction: Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features
por: Flanagan, Dustin J., et al.
Publicado: (2023)

Correction: SHP-1 regulates hematopoietic stem cell quiescence by coordinating TGF-β signaling
por: Jiang, Linjia, et al.
Publicado: (2018)

Correction to: MSX2 suppression through inhibition of TGFβ signaling enhances hematopoietic differentiation of human embryonic stem cells
por: Wang, Hongtao, et al.
Publicado: (2020)

The tumor microenvironment drives NK cell metabolic dysfunction leading to impaired antitumor activity
por: Tumino, Nicola, et al.
Publicado: (2022)

Correction: Characterization of Negative Feedback Network Motifs in the TGF-β Signaling Pathway
por: Nicklas, Daniel, et al.
Publicado: (2014)

Correction: Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression
por: Grassadonia, Antonino, et al.
Publicado: (2021)

Correction: EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer
por: Schneck, Helen, et al.
Publicado: (2016)

Correction: Galactose Enhances Oxidative Metabolism and Reveals Mitochondrial Dysfunction in Human Primary Muscle Cells
por: Aguer, Céline, et al.
Publicado: (2012)

Correction: Galactose Enhances Oxidative Metabolism and Reveals Mitochondrial Dysfunction in Human Primary Muscle Cells
por: Aguer, Céline, et al.
Publicado: (2012)

Author Correction: Convergence of TGFβ and BMP signaling in regulating human bone marrow stromal cell differentiation
por: Elsafadi, Mona, et al.
Publicado: (2019)

Author Correction: Convergence of TGFβ and BMP signaling in regulating human bone marrow stromal cell differentiation
por: Elsafadi, Mona, et al.
Publicado: (2023)

Correction: Correction: Correction: Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion
Publicado: (2017)

Correction to: Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
por: Kremer, Veronika, et al.
Publicado: (2017)

Correction: TGF-β Prevents Phosphate-Induced Osteogenesis through Inhibition of BMP and Wnt/β-Catenin Pathways
Publicado: (2014)

Correction: Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy
por: Arnon, Tal I., et al.
Publicado: (2008)

Correction: Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy
por: Arnon, Tal I., et al.
Publicado: (2015)

Correction: Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II
Publicado: (2014)

Correction: Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II
por: Dituri, Francesco, et al.
Publicado: (2013)

Correction to: Influence of mechanical and TGF-β3 stimulation on the tenogenic differentiation of tonsil-derived mesenchymal stem cells
por: Wee, Jaeyeon, et al.
Publicado: (2022)

Correction: Overexpression of SMC4 activates TGFβ/Smad signaling and promotes aggressive phenotype in glioma cells
por: Jiang, L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r2620huitqgf4jmdq0in2c1ahp